(Q48886806)

16 February 2018

title

8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors (English)

1 reference

16 February 2018

1 reference

Hajós-Korcsok E

1

1 reference

16 February 2018

Sharp T

series ordinal

2

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 October 1996

1 reference

16 February 2018

European Journal of Pharmacology

published in

1 reference

16 February 2018

volume

314

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

285-291

1 reference

16 February 2018

(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Serotonin-specific drugs for anxiety and depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

A critical role for D1 receptors in the 5-HT1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Serotonergic regulation of noradrenergic coerulean neurons: electrophysiological evidence for the involvement of 5-HT2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Blockade of 8-OH-DPAT-induced feeding by dopamine antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Effects of p-chlorophenylalanine on cortical monoamines and on the activity of noradrenergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetralin: Involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5‐hydroxytryptamine1A receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900560-2

10.1016/S0014-2999(96)00560-2

7 January 2021

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018